Reducing Polycystic Liver Volume in ADPKD: Effects of Somatostatin Analogue Octreotide
摘要：
Background and objectives: No medical treatment is available for polycystic liver disease, a frequent manifestation of autosomal-dominant polycystic kidney disease (ADPKD). In a prospective, randomized, double-blind, crossover study, 6 months of octreotide (40 mg every 28 days) therapy limited kidney volume growth more effectively than placebo in 12 patients with ADPKD.
展开
关键词：
Humans Liver Kidney Cysts Polycystic Kidney Diseases Liver Diseases Octreotide Tomography, Spiral Computed Treatment Outcome Prospective Studies
DOI：
10.2215/CJN.05380709
被引量：
年份：
2010
Wiley
掌桥科研
dx.doi.org
Europe PMC
NCBI
查看更多
Oxford Univ Press
NCBI
NCBI
(全网免费下载)
ResearchGate
(全网免费下载)
ResearchGate
Citeseer
(全网免费下载)
giuseppedibella.it
mayoclinicproceedings.org
pkdiet.com
(全网免费下载)
d.scholar.cnki.net
sin-italy.org
aisberg.unibg.it
pubfacts.com
cjasn.asnjournals.org
physiolgenomics.physiology.org
moh-it.pure.elsevier.com
onAcademic
学术范
(全网免费下载)
hdl.handle.net
学术范
scialert.net
cjasn.asnjournals.org
(全网免费下载)
symedicine.org
core.ac.uk
mysciencework.com
cghjournal.org
NCBI
(全网免费下载)
ResearchGate
(全网免费下载)
Citeseer
(全网免费下载)
cjasn.asnjournals.org
(全网免费下载)
pkdiet.com
(全网免费下载)
学术范
(全网免费下载)
通过文献互助平台发起求助，成功后即可免费获取论文全文。
相似文献
参考文献
引证文献
辅助模式
引用
文献可以批量引用啦~
欢迎点我试用！
